Avance Clinical News

  1. Avance Clinical CEO And Asia Director Sign MOUs With Key Clinical Trial Sites In Korea Around 2024 KoNECT 10/30/2024

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.

  2. Join Avance Clinical At Biotech Showcase 2025 10/17/2024

    Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.

    With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.

  3. Join Avance Clinical At The CNS Summit 2024 10/17/2024

    Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.

  4. 2024 KoNECT-MOHW-MFDS International Conference (KIC) Meet Avance in Seoul 10/17/2024

    Avance Clinical is proud to announce our attendance at the 2024 KoNECT-MOHW-MFDS International Conference (KIC) in Seoul, South Korea, October 29 – 31, 2024. As part of our commitment to expanding our global presence and strengthening our capabilities in the Asia-Pacific region, CEO Yvonne Lungershausen and Asia Regional Director Jessica Han will be attending the conference, meeting with biotech clients and partners to discuss opportunities in early and late-phase clinical trials.

  5. Avance Clinical Welcomes Kelly Yang As Associate Director, Operations Taiwan 10/17/2024

    Avance Clinical, a leading global contract research organization (CRO) specializing in advanced clinical research solutions for biotechs, is excited to announce the appointment of Kelly Yang as Associate Director, Operations Taiwan. Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.

  6. Avance Clinical GlobalReady Site Partnership Network Expands Rapidly To 2,000 Site Members 9/4/2024
  7. Avance Clinical Wins 2024 Frost & Sullivan Award For Global Biotech CRO Excellence 8/28/2024

    Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.

  8. Avance Clinical Appoints Asia Regional Director As Part Of Global Expansion Program 7/22/2024

    Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of the Avance Clinical’s Seoul, Korea office.

  9. Avance Clinical Welcomes Joe Taouk As Vice President, Global Project Delivery 6/28/2024

    Avance Clinical, the largest specialist Australian and US CRO, is thrilled to announce the appointment of Joe Taouk as Vice President, Global Project Delivery.

  10. New Research Launched At BIO24 Finds CROs With In-House Regulatory Affairs Deliver 30% Savings, Halve Timelines And Cut Risk For Biotechs 6/4/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.